The Citing articles tool gives a list of articles citing the current article. The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
This article has been cited by the following article(s):
Factors Affecting Willingness to Use Indoor Residual Spraying Among Pregnant Women Attending Antenatal Care in Hyperendemic State of West Africa: A Random Survey
Tunji Oloyede Oladoyinbo, Adedapo Olufemi Adeogun, Ayodele Samuel Babalola, et al. Journal of Medical Entomology 58(6) 2368 (2021) https://doi.org/10.1093/jme/tjab132
Cyclic Tetrapeptide HDAC Inhibitors with Improved Plasmodium falciparum Selectivity and Killing Profile
Imatinib augments standard malaria combination therapy without added toxicity
Huynh Dinh Chien, Antonella Pantaleo, Kristina R. Kesely, Panae Noomuna, Karson S. Putt, Tran Anh Tuan, Philip S. Low and Francesco M. Turrini Journal of Experimental Medicine 218(10) (2021) https://doi.org/10.1084/jem.20210724
Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures
Mechanism of Action of N-Acyl and N-Alkoxy Fosmidomycin Analogs: Mono- and Bisubstrate Inhibition of IspC from Plasmodium falciparum, a Causative Agent of Malaria
Jean-Jacques Helesbeux, Laura Carro, Florence O. McCarthy, Vânia M. Moreira, Francesca Giuntini, Niamh O’Boyle, Susan E. Matthews, Gülşah Bayraktar, Samuel Bertrand, Christophe Rochais and Pascal Marchand Pharmaceuticals 14(12) 1278 (2021) https://doi.org/10.3390/ph14121278
Absence of Plasmodium falciparum artemisinin resistance gene mutations eleven years after the adoption of artemisinin-based combination therapy in Nigeria
Discovery of 6′-chloro-N-methyl-5’-(phenylsulfonamido)-[3,3′-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium
Xiaofei Liang, Zongru Jiang, Zhenghui Huang, Feng Li, Cheng Chen, Chen Hu, Wenliang Wang, Zhenquan Hu, Qingwang Liu, Beilei Wang, Li Wang, Ziping Qi, Jing Liu, Lubin Jiang and Qingsong Liu European Journal of Medicinal Chemistry 188 112012 (2020) https://doi.org/10.1016/j.ejmech.2019.112012
Gabriel J. Foster, Katrina Button-Simons, Katelyn Vendrely, Jeanne Romero-Severson and Michael T. Ferdig (2020) https://doi.org/10.1101/2020.04.17.044552
Vital role forPlasmodium bergheiKinesin8B in axoneme assembly during male gamete formation and mosquito transmission
J. O. Adebayo, H. Tijjani, A. P. Adegunloye, A. A. Ishola, E. A. Balogun and S. O. Malomo Parasitology Research 119(9) 2749 (2020) https://doi.org/10.1007/s00436-020-06786-1
Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia
Plasmodium stage-selective antimalarials from Lophira lanceolata stem bark
Harouna Soré, Annalisa Lopatriello, Yehenew A. Ebstie, Alain R. Tenoh Guedoung, Adama Hilou, José A. Pereira, Anake Kijjoa, Annette Habluetzel and Orazio Taglialatela-Scafati Phytochemistry 174 112336 (2020) https://doi.org/10.1016/j.phytochem.2020.112336
Post-Marketing Surveillance of Quality of Artemether Injection Marketed in Southwest Nigeria
Ibrahim A. Hassan, Adebanjo J. Adegbola, Julius O. Soyinka, Cyprian O. Onyeji and Oluseye O. Bolaji
The American Journal of Tropical Medicine and Hygiene 103(3) 1258 (2020) https://doi.org/10.4269/ajtmh.20-0190
Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria
Yobouet Ines Kouakou, Michel Tod, Gilles Leboucher, Adeline Lavoignat, Guillaume Bonnot, Anne-Lise Bienvenu and Stephane Picot International Journal of Infectious Diseases 89 30 (2019) https://doi.org/10.1016/j.ijid.2019.08.030
Plasmodium
Genomics and Genetics: New Insights into Malaria Pathogenesis, Drug Resistance, Epidemiology, and Evolution
Xin-zhuan Su, Kristin D. Lane, Lu Xia, Juliana M. Sá and Thomas E. Wellems Clinical Microbiology Reviews 32(4) (2019) https://doi.org/10.1128/CMR.00019-19
Global Catastrophic Biological Risks
Emily Ricotta and Jennifer Kwan Current Topics in Microbiology and Immunology, Global Catastrophic Biological Risks 424 33 (2019) https://doi.org/10.1007/82_2019_163
Improvement of Asparagine Ethylenediamines as Anti-malarial Plasmodium-Selective Proteasome Inhibitors
Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties